Globe Biotech
Phase I trial of Bangavax approved
The government today (July 17, 2022) approved phase I clinical trial of Bangavax, a homegrown coronavirus vaccine developed by Globe Biotech.
July 17, 2022
Phase I trial of Bangavax approved
The government today (July 17, 2022) approved phase I clinical trial of Bangavax, a homegrown coronavirus vaccine developed by Globe Biotech.
X